Filing Details

Accession Number:
0001493152-22-033261
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-22 10:18:49
Reporting Period:
2022-11-21
Accepted Time:
2022-11-22 10:18:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335105 Lixte Biotechnology Holdings Inc. LIXT Pharmaceutical Preparations (2834) 202903526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862089 Regina Brown 680 E. Colorado Blvd.,
Suite 180
Pasadena CA 91101
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-21 2,400 $0.57 3,700 No 4 P Direct
Common Stock Acquisiton 2022-11-21 2,600 $0.58 6,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct